Recent Finacing
Recent Raise
Tetragenetics develops TetraExpress protein-expression and G-SOME particle platforms to produce folded ion-channel and vaccine antigens for antibody discovery, small-molecule screening, and particle-based malaria vaccine development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors